CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411505029
- Phone
- 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · Other events
- 8-K Event Regulation FD disclosure
- 424B4 Offering Prospectus
- S-1MEF Other S-1MEF
- CERTNAS Other Certification by the Nasdaq Stock Market
- 8-A12B Other Registration of Securities
- 8-K Event Regulation FD disclosure · Other events
- EFFECT Other Notice of Effectiveness
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 24 of 72 · 1,429 filings